IXHL(IXHL)
IXHL
Analyst Coverage
No analyst coverage available for this stock.
Key MetricsTTM
Market Cap$41.16M
Revenue TTM$66.6K
Net Income TTM-$49.94M
Free Cash Flow-$17.04M
Gross Margin-181.0%
Operating Margin-44992.2%
Net Margin-77280.2%
Return on Equity-176.0%
Return on Assets-68.6%
Debt / Equity0.00
Current Ratio48.27
EPS TTM$-4.42
PRICE
Prev Close
3.64
Open
3.67
Day Range3.56 – 3.71
3.56
3.71
52W Range2.49 – 49.80
2.49
49.80
2% of range
VOLUME & SIZE
Avg Volume
554.0K
FUNDAMENTALS
P/E Ratio
-0.2x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
TECHNICAL
RSI (14)
41
Bearish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 23
DEx-Dividend
In 90 days
Aug 20
PDividend Pay
In 119 days
Sep 18
IXHL News
About
No description available.
Country
Australia
Lekhram ChangoerChief Technology Officer & Member of Advisory Board
John Michailidis EMBAChief Executive Officer of IncannexTM
Natalie MayHead of Clinical Operations
Joseph SwanChief Financial Officer, Treasurer & Secretary
Luigi BarbatoChief Medical Officer
Mark BleackleyChief Scientific Officer, Head of Programs & Member of the Advisory Board
Joel Bradley LathamPresident, Chief Executive Officer & Executive Director